MedPath

The Effect of Acute Intermittent Hypoxia on Motor Learning

Not Applicable
Completed
Conditions
Incomplete Spinal Cord Injury
Interventions
Other: SHAM Acute Intermittent Hypoxia
Other: Acute Intermittent Hypoxia
Registration Number
NCT05341466
Lead Sponsor
University of Colorado, Boulder
Brief Summary

The goal of this study is to examine the effect of repetitive acute intermittent hypoxia on motor learning abilities in able-bodied individuals for subsequent study in individuals with incomplete spinal cord injury.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
56
Inclusion Criteria
  • 18 to 70 years old (the latter to reduce likelihood of heart disease);
  • Medically stable with medical clearance from physician to participate;
  • Motor-incomplete spinal cord injuries at or below C2 and at or above L5;
  • AIS A-D at initial screen, or other non-traumatic spinal cord injury disorders (e.g. multiple sclerosis, ALS, tumors, acute transverse myelitis, etc.);
  • More than 1 year since iSCI to minimize confounds of spontaneous neurological recovery;
  • Ability to advance one step overground with or without assistive devices;
Exclusion Criteria
  • Severe concurrent illness or pain;
  • Recurrent autonomic dysreflexia;
  • History of cardiovascular/pulmonary complications;
  • Concurrent physical therapy;
  • Pregnant at time of enrollment or planning to become pregnant;
  • Untreated painful musculoskeletal dysfunction, fracture or pressure sore;
  • History of seizures or epilepsy;
  • Recurring headaches;
  • Concussion within the last six months;
  • Depression or manic disorders
  • Metal implants in the head, or pacemaker.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SHAM Acute Intermittent HypoxiaSHAM Acute Intermittent Hypoxia5 consecutive days of 15, 1.5 min episodes at 21% O2 (SHAM AIH) alternating with 21% O2 at 1 min intervals
Repetitive Acute Intermittent HypoxiaAcute Intermittent Hypoxia5 consecutive days of 15, 1.5 min episodes at 9% O2 (AIH) alternating with 21% O2 at 1 min intervals
Primary Outcome Measures
NameTimeMethod
Change in Corticospinal ExcitabilityWe will measure TMS before the start of 5 consecutive days of AIH or SHAM treatment. We will measure TMS within 24 hours of the final treatment.

Transcranial magnetic stimulation (TMS) can be applied over the primary motor cortex to examine changes in corticospinal excitability. The downstream muscle activation can be recorded with surface EMG as a motor-evoked potential (MEP). The peak-to-peak MEP amplitude (mV) is as an index of corticospinal excitability.

A randomized sequence of TMS intensities can be applied over the primary motor cortex, ranging from 90-140% of the participants' resting motor threshold (RMT). The mean MEP amplitude will be plotted against the corresponding stimulation intensity to produce the recruitment curve. The area under the recruitment curve is an additional index of corticospinal excitability (mV/% RMT).

Step Length AsymmetryWe will compare asymmetry 15 minutes after the final AIH treatment to asymmetry following no treatment (control group).

Step length asymmetry will be quantified as the ratio of the normalized difference in step lengths between the fast and slow legs during split-belt motor adaptation: (Fast leg - Slow leg step length) / (Fast leg + Slow leg step length).

Step Time AsymmetryWe will compare asymmetry 15 minutes after the final AIH treatment to asymmetry following no treatment (control group).

Step time asymmetry will be quantified as the ratio of the normalized difference in step times between the fast and slow legs during split-belt motor adaptation: (Fast leg - Slow leg step time) / (Fast leg + Slow leg step time).

Net Metabolic PowerWe will compare net metabolic power 15 minutes after the final AIH treatment to asymmetry following no treatment (control group).

Using expired gas analyses, we will calculate net metabolic power by inputting steady-state values for V̇O₂ and V̇CO₂ into standard regression equations (W), subtracting resting values, and normalizing the result to each participant's body weight (kg).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

University of Colorado

🇺🇸

Boulder, Colorado, United States

University of Colorado, Anschutz Medical Campus

🇺🇸

Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath